Phase 2 Type 2 Diabetes Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Type 2 Diabetes.
- People between the ages of 40 and 65 years old.
- People who are willing to take part in the study and sign a consent form after having the research process fully explained to them.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have serious other health conditions that could affect the immune system, such as autoimmune diseases, cancer, or severe infections.
- People who are currently taking blood-thinning medication.
- People who are currently taking medication that suppresses the immune system.
- Women who are pregnant, as the effects of the therapy being studied have not been sufficiently researched in pregnancy.
- People who have a history of severe allergic reactions to any of the components used in the therapy being studied.
- People who have chronic kidney disease and are currently receiving dialysis treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 085227700340
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Where this trial is recruiting
Primary endpoints
Fasting Blood Glucose (FBG); 2-Hour Postprandial Glucose; HbA1c; C-peptide
Can't join this trial?
Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.